Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth Smyth

Showing results (1-10 of 87) with videos related to

Pageof 9
Sort By:
The Lancet. Oncology|November 7, 2017
Missing a GOLDen opportunity in gastric cancerElizabeth Smyth
Expert Opinion on Investigational Drugs|December 19, 2025
Promising investigational agents for gastro-oesophageal junction adenocarcinomaAntonella Cammarota, Elizabeth Smyth
Clinical Medicine (London, England)|January 25, 2013
Gastrointestinal oncology--what you need to knowElizabeth Smyth, David Cunningham
Current Pharmaceutical Design|March 7, 2012
Anti-VEGF strategies - from antibodies to tyrosine kinase inhibitors: background and clinical development in human cancerGrzegorz Korpanty, Elizabeth Smyth
Expert Review of Anticancer Therapy|December 22, 2020
Evolving therapies in advanced oesophago-gastric cancers and the increasing role of immunotherapyHossameldin Attia, Elizabeth Smyth
Annals of Translational Medicine|June 19, 2018
Translational research and application of basic biology to clinical trial development in GI cancersElizabeth Smyth, Khurum Khan, Nicola Valeri
Expert Reviews in Molecular Medicine|June 9, 2021
Anti-cancer therapy with cyclin-dependent kinase inhibitors: impact and challengesMarika A V Reinius, Elizabeth Smyth
Therapeutic Advances in Medical Oncology|December 8, 2022
Immune checkpoint inhibitors in resectable gastroesophageal cancers - a reviewSarbajit Mukherjee, Kanak Parmar, Elizabeth Smyth
BMC Family Practice|August 9, 2018
Job satisfaction and career intentions of registered nurses in primary health care: an integrative reviewElizabeth Halcomb, Elizabeth Smyth, Susan McInnes
Oncology Research and Treatment|April 30, 2018
Immune Checkpoint Inhibition in Gastro-Oesophageal CancerElizabeth Smyth, Peter C Thuss-Patience
Pageof 9

Showing results (1-10 of 87) with videos related to

Sort By:
Pageof 9
The Lancet. Oncology|November 7, 2017
Missing a GOLDen opportunity in gastric cancerElizabeth Smyth
Expert Opinion on Investigational Drugs|December 19, 2025
Promising investigational agents for gastro-oesophageal junction adenocarcinomaAntonella Cammarota, Elizabeth Smyth
Clinical Medicine (London, England)|January 25, 2013
Gastrointestinal oncology--what you need to knowElizabeth Smyth, David Cunningham
Current Pharmaceutical Design|March 7, 2012
Anti-VEGF strategies - from antibodies to tyrosine kinase inhibitors: background and clinical development in human cancerGrzegorz Korpanty, Elizabeth Smyth
Expert Review of Anticancer Therapy|December 22, 2020
Evolving therapies in advanced oesophago-gastric cancers and the increasing role of immunotherapyHossameldin Attia, Elizabeth Smyth
Annals of Translational Medicine|June 19, 2018
Translational research and application of basic biology to clinical trial development in GI cancersElizabeth Smyth, Khurum Khan, Nicola Valeri
Expert Reviews in Molecular Medicine|June 9, 2021
Anti-cancer therapy with cyclin-dependent kinase inhibitors: impact and challengesMarika A V Reinius, Elizabeth Smyth
Therapeutic Advances in Medical Oncology|December 8, 2022
Immune checkpoint inhibitors in resectable gastroesophageal cancers - a reviewSarbajit Mukherjee, Kanak Parmar, Elizabeth Smyth
BMC Family Practice|August 9, 2018
Job satisfaction and career intentions of registered nurses in primary health care: an integrative reviewElizabeth Halcomb, Elizabeth Smyth, Susan McInnes
Oncology Research and Treatment|April 30, 2018
Immune Checkpoint Inhibition in Gastro-Oesophageal CancerElizabeth Smyth, Peter C Thuss-Patience
Pageof 9